Evonik invests in Biosynthetic Technologies

Biosynthetic Technologies markets biodegradable, high-performance lubricants

18-Jul-2014 - Germany

Evonik has closed on an equity investment in Biosynthetic Technologies, LLC (BT), a specialist in biobased lubricants headquartered in Irvine (California, USA). BT has developed and manufactures a new class of bio-based synthetic oils called estolides that are used primarily in the passenger car motor oil and industrial lubricant sectors. Field trials have shown that the technical characteristics of the biobased synthetic oils made by BT are exceptionally good, and include the ability to combat soot buildup in engines, which helps keep fuel consumption low. In addition to Evonik, BP Ventures also participated as a second strategic investor in this current funding round that focuses on growth. BP Ventures as well as Monsanto Company have already invested in previous financing rounds.

“Biosynthetic Technologies leads the way to high-quality sustainable lubricants,” says Dr. Bernhard Mohr, head of Evonik Venture Capital. “In view of the large automotive market and the strong trend towards fuel-economy and sustainability, this is a growing market with a strong fit to Evonik´s oil additives business."

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!